Investing Profile

Mike Ross

InvestorVC
Managing Partner at SV Health Investors
svhealthinvestors.comSan Mateo, California
Photo of Mike Ross, Managing Partner at SV Health Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
SV Health Investors Managing Partner
$100K - $5.0M
$1.5M
15
£200M
CompanyStageDateRound SizeTotal Raised
Eyebiotech
Series ANov 2023$65M
Series AFeb 2022$65M
SeedAug 2021
$130M
Co-investors: Kate Bingham (SV Health Investors), Bernard Davitian (Omega Funds)
Therini Bio
Series AApr 2023$36M
SeedMay 2021$17M
SeedJul 2019$9M
$62M
Co-investors: Laurence Barker (SV Health Investors), Pascal Levensohn (Dolby Family Ventures), Jim Trenkle (Sanofi Ventures), Houman Ashrafian (SV Health Investors)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
Series ASep 2018$30M
$330M
Co-investors: Jayson Punwani (Abingworth), Nancy Hong (RiverVest), Jack Kenney (SV Health Investors), Peter Dudek (MRL Ventures Fund), Andrew Hack (Bain Capital Life Sciences)
Thesan Pharmaceuticals
Series BJan 2016
Series BFeb 2014$49M
$65M
Co-investors: Giovanni Ferrara
Avitide
Series CAug 2015$8M
Series AMar 2013$1M
$21M
Co-investors: Phil Ferneau (Borealis Ventures)
Arsanis
Series AFeb 2011$10M
$76M
Co-investors: Carl Gordon (OrbiMed), Amy Schulman (Polaris Partners), Terry McGuire (Polaris Partners)
Archemix
Series AAug 2002$52M
$100M
Co-investors: Peter Barrett (Atlas Venture)